Global nuclear medicine market is
estimated to grow at a rate of 2% during the forecast period owing to increasing
incidence and prevalence of diseases like cancer, initiatives to reduce the
demand and supply gap of Mo-99 and increasing research and development
activities in radiotherapy to treat various diseases. Furthermore, nuclear medicines are
extensively being used in molecular imaging, which is a technique involving
molecules as biomarkers for specific molecular processes that determines the
onset or progress of a disease.
Nuclear medicines are convenient
and safer alternative for patients as compared to X-Rays and other external
radiation imaging devices. Due to this major factor, chemotherapy methods are
being replaced by radiopharmaceuticals or nuclear medicines for cancer
treatment. They are also used in applications such as lymphoma and bone
metastasis. Some of the nuclear medicines used in diagnostic procedures are F-18,
Tc-99, Ga-67, and I-123 while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223
are used in therapeutics procedures. These factors are anticipated to drive
global nuclear medicine market until 2025.
Apart from above mentioned growth
factors, the global nuclear medicine market also faces some restrains. Short
half-life of nuclear medicines or radiopharmaceuticals reduces their potential
adoption. Other restraining factors include supply shortages, logistical
difficulties, and limited number of trained medical personnel.
The global nuclear medicine market
is segmented based on therapy, type, application, therapeutics, route of administration,
end-user and region. Based on application, the global nuclear medicine market
is segmented into cardiology, respiratory, orthopaedics, neurology, oncology
and urology. Among them, the oncology segment accounts for the major market
share due to increasing prevalence of cancer worldwide. Based on type, the
nuclear medicine market is segmented into SPECT, PET. The PET segment accounts
for 80% of the oncology market whereas SPECT contributing majorly for other
applications like cardiology, nephrology and neuroendocrine.
Major players operating in the global
nuclear medicine market include Cardinal Health, Curium, Lantheus, Bracco,
Advanced Accelerator Applications, NTP Radioisotopes, Eckert & Ziegler,
Jubilant DraxImage, GE Healthcare, Siemens Healthineers, Rotem Industries,
Eczacibasi-Monrol, IBA Group, Ire-Elit, Lucerno Dynamics, Positron Corporation,
NorthStar Medical Radioisotopes, Pharmalucence, Norgine, Roche and others. Key
market players are implementing activities like product developments, business
expansion, and collaborative development to maintain significant share in the
market for nuclear medicine.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the
Study:
·
To analyze and forecast the market size of global nuclear medicine market.
·
To classify and forecast global nuclear medicine market based on therapy,
type, application, therapeutics, route of administration, end-user, company and regional distribution.
·
To identify drivers and challenges for global nuclear medicine market.
·
To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in global nuclear medicine market.
·
To conduct pricing analysis for global nuclear medicine market.
·
To identify and analyze the profile of leading players operating in global
nuclear medicine market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of global nuclear medicine market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
·
Nuclear medicine manufacturer, suppliers,
distributors and other stakeholders
·
Hospitals & Clinics
·
Government bodies such as regulating authorities
and policy makers
·
Organizations, forums and alliances related to nuclear
medicine
·
Market research and consulting firms
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, global nuclear medicine
market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
·
Market, By Therapy:
o
Radioactive Iodine
o
Radioactive Antibodies
o
Radioactive Phosphorus
o
Others
·
Market, By Type:
o SPECT
(Single Photo Emission Computed Tomography)
o PET (Positron
Emission Tomography)
·
Market, By Application:
o Cardiology
o Respiratory
o Orthopaedics
o Neurology
o Oncology
o Urology
·
Market, By Therapeutics:
o Alpha
Particle Emitters
o Beta
Particle Emitters
o Auger
Electron Emitters
·
Market, By Route of Administration:
o Oral
o Intravenous
o Nasal
·
Market, By End-User:
o Hospitals
o Diagnostic
Centers
o Others
·
Market, By Region:
o Asia-Pacific
o Europe
o North America
o South America
o Middle East & Africa
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in global nuclear medicine market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
·
Detailed
analysis and profiling of additional market players (up to five).
It is an upcoming report to
be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at sales@techsciresearch.com
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com